Yu Kyeong Ri, Keller-Biehl Lucas, Smith-Harrison Leon, Hazell Sarah Z, Timmerman William R, Rivers Jeannie F, Miller Thomas A
Department of Surgery, Richmond VA Medical Center, 1201 Broad Rock Blvd, Richmond, VA 23249, United States.
Department of Surgery, Virginia Commonwealth University Health System, 3600W Broad St, Richmond, Virginia 23230, United States.
Surg Pract Sci. 2023 Sep 9;15:100216. doi: 10.1016/j.sipas.2023.100216. eCollection 2023 Dec.
This study was undertaken to evaluate our 16-year experience with fistulas between the rectum and urethra or urinary bladder, collectively called recto-urinary fistulas (RUFs), and their devastating consequences in patients treated with radiation for prostate cancer.
We downloaded the records of all patients with radiation-related RUFS from 2004 to 2020 at our institution using the electronic medical record system. Details concerning patient demographics, clinical presentation, diagnostic approaches and surgical management were obtained and assessed.
We identified a total of seven patients with radiation-induced RUFS: all were male and had an average age of 66 at diagnosis. Each had a history of prostate cancer that was treated with external, internal (i.e.brachytherapy), or combination radiation therapy. No fistulas were noted in patients treated with radiation for another malignancy. Radiation proctitis with rectal ulcer formation occurred in 6 of 7 patients. Common symptoms included fecaluria, pneumaturia, urine leakage via rectum, rectal pain and urinary tract infection. CT scanning was the most useful diagnostic tool. Once confirmed, fistula management included both urinary and fecal diversion in all patients. Only one patient received definitive repair of the fistula. Five others either died before repair could be attempted or had prohibitive co-morbid diseases. One patient declined repair.
Although rare, the development of a recto-urinary fistula is a dreaded complication. Our results indicate that radiation proctitis with rectal ulcer formation precedes fistula formation in most patients and must be aggressively managed. While fecal and urinary diversion can manage fistula symptoms in the majority of patients, definitive fistula repair is only possible in selected individuals.
本研究旨在评估我们在直肠与尿道或膀胱之间瘘管(统称为直肠泌尿瘘,RUFs)方面16年的经验,以及它们对接受前列腺癌放疗患者造成的严重后果。
我们使用电子病历系统下载我院2004年至2020年所有与放疗相关的RUFs患者的记录。获取并评估有关患者人口统计学、临床表现、诊断方法和手术治疗的详细信息。
我们共确定了7例放疗诱发的RUFs患者:均为男性,诊断时平均年龄66岁。每位患者都有前列腺癌病史,接受过外照射、内照射(即近距离放疗)或联合放疗。接受放疗治疗其他恶性肿瘤的患者未发现瘘管。7例患者中有6例发生了伴有直肠溃疡形成的放射性直肠炎。常见症状包括粪尿症、气尿症、经直肠尿液渗漏、直肠疼痛和尿路感染。CT扫描是最有用的诊断工具。一旦确诊,所有患者的瘘管处理包括尿路改道和粪流改道。只有1例患者接受了瘘管的确定性修复。另外5例患者要么在尝试修复前死亡,要么有严重的合并症。1例患者拒绝修复。
尽管罕见,但直肠泌尿瘘的发生是一种可怕的并发症。我们的结果表明,大多数患者在瘘管形成之前会出现伴有直肠溃疡形成的放射性直肠炎,必须积极处理。虽然粪流改道和尿路改道可以控制大多数患者的瘘管症状,但只有部分患者能够进行瘘管的确定性修复。